Response of bone turnover markers to raloxifene treatment in postmenopausal women with osteopenia

Response of bone turnover markers to three oral bisphosphonate therapies in postmenopausal osteoporosis: the TRIO study

(2015) K. E. Naylor et al.   OSTEOPOROSIS INTERNATIONAL

Comparison of the effects of three oral bisphosphonate therapies on the peripheral skeleton in postmenopausal osteoporosis: the TRIO study

(2014) M. A. Paggiosi et al.   OSTEOPOROSIS INTERNATIONAL

Adherence to raloxifene therapy: assessment methods and relationship with efficacy

(2013) J. Finigan et al.   OSTEOPOROSIS INTERNATIONAL

Evaluation of urinary N-telopeptide of type I collagen measurements in the management of osteoporosis in clinical practice

(2012) I. Baxter et al.   OSTEOPOROSIS INTERNATIONAL

The potential value of monitoring bone turnover markers among women on alendronate

(2011) Katy JL Bell et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Effects of raloxifene and alendronate on bone turnover as assessed by procollagen type I N-terminal propeptide

(2010) R. Eastell et al.   OSTEOPOROSIS INTERNATIONAL

Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards

(2010) S. Vasikaran et al.   OSTEOPOROSIS INTERNATIONAL

The effect of cessation of raloxifene treatment on bone turnover in postmenopausal women

(2009) K.E. Naylor et al.   BONE

Laboratory reproducibility of biochemical markers of bone turnover in clinical practice

(2009) A. L. Schafer et al.   OSTEOPOROSIS INTERNATIONAL

Utility of Biochemical Markers of Bone Turnover and Bone Mineral Density in Management of Osteoporosis

(2008) Samuel D. Vasikaran   CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES

Evidence-based guidelines for the use of biochemical markers of bone turnover in the selection and monitoring of bisphosphonate treatment in osteoporosis: a consensus document of the Belgian Bone Club

(2008) P. Bergmann et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE